MML Investors Services
SLS icon

MML Investors Services’s SELLAS Life Sciences SLS Stock Holding History

MML Investors Services’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,024
Closed -$29K – 1702
2020
Q3 		$29K Buy
+11,024
New +$30.2K ﹤0.01% 1563
2019
Q4 		– Sell
-1,320
Closed -$8K – 1550
2019
Q3 		$8K Buy
+1,320
New +$9.73K ﹤0.01% 1466

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

MML Investors Services's SLS Position: Q4 2020 in Review

MML Investors Services sold out of SELLAS Life Sciences (SLS) in Q4 2020, closing a stake of 11,024 shares — an estimated $29K sold.

MML Investors Services first reported a position in SLS in Q3 2019 and held it in 2 quarters. The position peaked at $29K in Q3 2020. 21 funds tracked by Wall St. Rank hold SLS as of Q4 2020.

  • MML Investors Services reported no remaining SELLAS Life Sciences position as of Q4 2020 after selling out during the quarter.
  • MML Investors Services sold 11,024 SELLAS Life Sciences shares in Q4 2020, an estimated $29K.
  • MML Investors Services first reported a position in SELLAS Life Sciences in Q3 2019 and held it in 2 quarters.
  • MML Investors Services's SELLAS Life Sciences position peaked at $29K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2020.

Based on MML Investors Services's 13F filing for Q4 2020, filed 12 Feb 2021.